FDA Approves Brain Tumor Drug, Afinitor

by VR Sreeraman on  October 31, 2010 at 10:18 AM Drug News   - G J E 4
Swiss pharmaceutical company Novartis said Saturday that the US Food and Drug Administration had approved a drug for treating certain benign brain tumors which previously required surgery.
 FDA Approves Brain Tumor Drug, Afinitor
FDA Approves Brain Tumor Drug, Afinitor

Everolimus, marketed as Afinitor, had been shown to be effective in reducing subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis, a genetic disorder affecting approximately 25,000 to 40,000 people, mainly children and adolescents, in the United States, it said.

Accelerated FDA approval was based on a study of 28 patients conducted by Cincinnati Children's Hospital Medical Center, in which nearly one-third of experienced a reduction of 50 percent or more in the size of their largest SEGA within six months, Novartis said.

The company said it was continuing to study the efficacy and clinical benefit of Afinitor in a wider trial, and had submitted marketing applications to the European Medicines Agency and the Swiss Agency for Therapeutic Products (Swissmedic).

If approved in the European Union for this indication, the treatment will be made available under the trade name Votubia, it said.

Source: AFP

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like